Preethi Sundaram - Dec 27, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Dec 27, 2022
Transactions value $
$0
Form type
4
Date filed
12/29/2022, 03:49 PM
Previous filing
Nov 15, 2022
Next filing
Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +68K +19.85% $0.00 411K Dec 27, 2022 Common Stock 68K $18.59 Direct F1
transaction CPRX Restricted stock units Award $0 +20K +4.87% $0.00 431K Dec 27, 2022 Common Stock 20K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.